Replies to post #9490 on Organovo Holdings, Inc. (ONVO)

[RandolRocketman]

The reason I bolded the

Mark Kessel is a partner of Symphony Capital, LLC, a private equity firm he co-founded in 2002 that invests in biopharmaceutical company clinical development programs.

is because I think soon we will see them headed into clinical trials for therapeutic tissue replacement. Say goodbye to transplant waiting lists!